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Introduction
Trisomy 18 was first described in 1960 by Edwards
et al [1]. It is the second most common autosomal
trisomy after trisomy 21, and the estimated birth
prevalence is 1 in 7,000 [2]. An excess of females 
is significantly noted in trisomy 18 live births, and
prenatal selection against male fetuses has been
documented. Molecular analysis of the extra copy of
chromosome 18 revealed over 90% of cases from a
maternal meiotic nondisjunction, especially meiosis II
errors [3]. Multiple severe structural abnormalities
of trisomy 18 mainly involve the heart, extremities,
face, and brain. A current study proposed downreg-
ulation of cholesterol synthesis as a possible etiol-
ogy in congenital malformations of trisomy 18 [4].
Because of the serious and lethal birth defects, tri-
somy 18 newborns often die within the first month
of life after delivery [5]. The mortality rate of tri-
somy 18 live births ranges from 20% to 90% during
the first year of life, and the remaining survivors are
profoundly neurologically damaged and mentally
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retarded [6–9]. At least 11 trisomy 18 patients
have been reported to have a long-term survival
past the age of 10 years [10–12].
Nowadays, ultrasound and multiple maternal
serum markers are clinically applied to detect fetuses
with trisomy 18. The sensitivity of sonographic de-
tection of fetuses with trisomy 18 was reported to
be approximately 70–100% [13–16]. Prenatal sono-
graphic features of trisomy 18 include congenital
heart defects, malformations of the central nerv-
ous system (CNS), facial anomalies, gastrointestinal
anomalies, defects of the limbs, intrauterine growth
restriction (IUGR), choroid plexus cysts (CPCs) and
increased nuchal translucency (NT) thickness or
cystic hygroma. A detailed understanding of the
various sonographic abnormalities for trisomy 18
fetuses can greatly improve prenatal detection of
this serious congenital anomaly. In addition, differ-
ential diagnosis of trisomy 18 syndrome, including
trisomy 18-like syndrome, Pena–Shokeir syndrome
type I and arthrogryposis multiplex congenital
(AMC), is discussed here (Table).
Prenatal Sonographic Features
Sonographic findings associated with fetal aneuploi-
dies can be classified as major structural anomalies or
minor anomalies (or soft markers). Major structural
anomalies related to trisomy 18 are anomalies of
the cardiovascular system, CNS, extremities, face,
and gastrointestinal system. Minor anomalies include
IUGR (< 10th centile), increased fetal NT, nuchal cys-
tic hygroma, CPC, absent fetal nasal bone, polyhy-
dramnios, single umbilical artery, and umbilical cord
cysts. Previous studies reported at least one abnor-
mal sonographic finding seen in fetuses with trisomy
18 [15,17,18]. The prenatal sonographic detection
of fetuses with trisomy 18 could be up to 100% by
an experienced sonographer [15].
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Table. Prenatal sonographic features of trisomy 18 and differential diagnosis
Prenatal sonographic features
Cardiac anomalies
ventricular septal defects, atrial septal defects, double-outlet right ventricle, patent ductus arteriosus, hypoplastic
left ventricle, tetralogy of Fallot, transposition of great vessels, endocardial cushion defects, mitral atresia, and
coarctation
Central nervous system anomalies
cerebellar hypoplasia, holoprosencephaly, anencephaly, agenesis of corpus callosum, ventriculomegaly, hydrocephaly,
strawberry-shaped head, brachycephaly, microcephaly, encephalocele, spina bifida and other neural tube defects
Facial anomalies
facial clefts, cyclopia, hypotelorism, short ear length, micrognathia, prominent occiput, and absence or hypoplasia
of nasal bone
Gastrointestinal anomalies or abdominal wall defects
omphalocele, congenital diaphragmatic hernia and esophageal atresia with tracheoesophageal fistula
Limb anomalies
clenched hands or overlapping digits, preaxial polydactyly, syndactyly, arthrogryposis, hypoplasia or aplasia of
the thumb and radius, clubfeet and rocker-bottom feet
Others
intrauterine growth restriction, choroid plexus cysts, increased nuchal translucency thickness, and cystic hygroma
Differential diagnosis
Trisomy 18-like syndrome
Pena–Shokeir syndrome type I
Arthrogryposis multiplex congenita
Cardiac anomalies
A wide spectrum of cardiac defects associated with
trisomy 18 include ventricular septal defects (VSD),
atrial septal defects (ASDs), double-outlet right 
ventricle (DORV), patent ductus arteriosus (PDA),
hypoplastic left ventricle, tetralogy of Fallot (TOF),
transposition of great vessels, endocardial cushion
defects, mitral atresia, coarctation, and others. In the
pathologic series of trisomy 18, cardiac anomalies
were universal and all the trisomy 18 cases mani-
fested various forms of complex structural malfor-
mations [19–22]. In a combined pathologic series,
the three most common defects were VSD (52%),
coarctation (19%) and TOF (10%) [23]. However,
prenatal echocardiography can detect most but
not all cases of trisomy 18 with congenital heart
defects throughout the gestation. Based on the
experience of the sonographers, the quality of
ultrasound equipment and diagnosis at gestational
weeks, prenatal sonographic detection of congenital
cardiac malformations of trisomy 18 have been
reported with wide ranges. In a large study of 174
trisomy 18 fetuses between 10 and 33 weeks of
gestation in London, cardiac anomalies were found
in 118 of 162 cases (72.8%) by prenatal echocar-
diography, of which ASD (29/162, 17.9%), VSD
(13/162, 8%) and coarctation (21/162, 13%) were
the most frequent findings [23]. In addition, they
found that cardiac malformations could be diag-
nosed reliably, even in the late first trimester. In an
analysis of 30 trisomy 18 fetuses in Korea, cardiac
anomalies were prenatally detected in 17 fetuses
(57%) throughout the gestation and in 15 fetuses
(50%) above 16 weeks of gestation. Almost all the
fetuses had VSD (16/17, 94%) [17]. In a retrospective
study of 89 trisomy 18 fetuses in Taiwan, 29 fetuses
(29/89, 32.6%) were found to have congenital
heart defects, and the most common abnormalities
were VSD in 26 cases (90%), ASD in 6 cases (20.7%),
and PDA in 6 cases (20.7%). They also found that
trisomy 18 male fetuses had more complex heart
defects (57% in males vs. 33% in females) [3,24].
In a second trimester study of 25 trisomy 18 cases
in Thailand, cardiac anomalies were seen in 9 cases
(36%), of which VSD and ASD were the most 
common features. In another second trimester study
of 70 trisomy 18 fetuses in Hungary, cardiac anom-
alies were the most common findings (33/70,
47.1%) by prenatal sonography, with the highest
incidence of VSD (19/33, 57.6%) [25]. In a first
trimester study of 45 fetuses with an NT of > 95th
centile, cardiac defects could be detected in three
out of six trisomy 18 fetuses by transvaginal echocar-
diography. The remaining two cases had minor
additional findings on postmortem examinations
and one was failure of examination [26]. They con-
cluded that the sensitivity and specificity for the
detection of heart defects by transvaginal echocar-
diography were 88% and 97%, respectively.
CNS anomalies
In trisomy 18, the reported associated CNS anom-
alies include cerebellar hypoplasia, holoprosencephaly
(HPE), anencephaly, agenesis of corpus callosum,
ventriculomegaly, hydrocephaly, encephalocele,
microcephaly, spina bifida, neural tube defects, and
others. In a European study of 120 trisomy 18 cases,
they found 16 cases (16/120, 13.3%) with CNS
anomalies, including hydrocephalus (5.0%), HPE
(1.7%), and others (6.7%) [16]. In a study of 25
trisomy 18 cases, 17 cases (17/25, 68%) had CNS
anomalies, including an enlarged cisterna magna
(20%), ventriculomegaly (16%), strawberry-shaped
head (12%), brachycephaly (12%) and HPE (8%)
[18]. In a study of 38 trisomy 18 cases, CNS anom-
alies were the most common anomalies in 33 cases
(87%), compared with cardiac anomalies in 32 cases
(84%) [15]. In a retrospective study of 89 trisomy
18 fetuses in Taiwan, 20 cases (20/89, 22.47%) were
found to have CNS anomalies manifesting cerebel-
lar hypoplasia, hydrocephalus-premaxillary agenesis,
HPE, and neural tube defects. These defects were
often detected prenatally in the second or third
trimester [27]. In the report, cerebellar hypoplasia
is the most common sign characterized by Dandy–
Walker malformation and an enlarged cisterna
magna. The abnormal sign of an enlarged cisterna
magna is often detected after 24 weeks of gesta-
tion [14]. In a review of 70 trisomy 18 cases, the
authors found 25 cases (25/70, 35.7%) having
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CNS anomalies with abnormal head shape (12.9%),
posterior fossa abnormality (11.4%), and ventricu-
lomegaly (11.4%) [25].
Facial anomalies
Orofacial abnormalities are common among trisomy
18 patients [28]. The perinatal facial anomalies of tri-
somy 18 include facial clefts, cyclopia, hypotelorism,
short ear length, micrognathia, prominent occiput,
and absence or hypoplasia of nasal bone. When
ocular anomalies or midline facial defects are seen
in association with HPE, chromosomal aneuploidy
should be highly considered. In different study set-
tings, prenatal sonographic findings of facial anom-
alies can be detected in approximately 14.3–37%
of trisomy 18 fetuses after the second trimester, and
facial clefts are the most frequent [17,18,25]. Median
and bilateral cleft-lips and palates, are the most com-
mon types [29]. In addition, absent fetal nasal bone
was detected in 68 out of 124 fetuses with trisomy
18 (54.8%) at 11–13+6 weeks of gestation [30,31].
Gastrointestinal anomalies or 
abdominal wall defects
The common gastrointestinal defects of fetal trisomy
18 include omphalocele, congenital diaphragmatic
hernia (CDH), and esophageal atresia with tracheoe-
sophageal fistula. The most frequent chromosomal
anomaly associated with omphalocele is trisomy 18,
especially the central type of omphalocele [32,33].
Prenatal detection of omphalocele in fetal trisomy 18
was reported, ranging from 7.1% to 36% through-
out gestation [17,18,25]. The early diagnosis of
omphalocele is often easy by prenatal ultrasound,
but we should be cautious about the diagnosis prior
to completion of the physiologic herniation. In a
study of 33 fetuses with CDH, six fetuses (6/33,
18.1%) had chromosomal abnormalities, especially
trisomy 18 [34].
Limb anomalies
The reported associated skeletal anomalies of 
fetal trisomy 18 include clubfeet, rocker-bottom
feet, clenched hands, polydactyly, syndactyly,
arthrogryposis, and limb deficiency. Trisomy 18 was
shown to have specific influence on the develop-
ment of preaxial component of the upper limb and
the tendency of hypoplasia or aplasia of the thumb
and radius [35]. Abnormalities in the upper extrem-
ities and hands were reported in about 95% (36/38)
of trisomy 18 fetuses [15]. Perinatal findings of
preaxial polydactyly include forms ranging from a
pedunculated supernumerary digit on the thumb to
a well-developed extra thumb, and the polydactyly
may occur, either on the left or right hand [29]. 
In a sonographic diagnosis of trisomy 18 at mid-
trimester, abnormal hands or feet can be detected
in 40% of fetuses (10/25) [18]. In another review
of 70 trisomy 18 fetuses, the sonographic detection
of limb anomalies with clenched hands and clubfeet
was only 5.7% (4/70) in the second trimester,
because evaluation of limb defects was not a routine
assessment in the setting at that time. In a study of
30 trisomy 18 fetuses, 14 fetuses (14/30, 47%) were
detected with limb anomalies throughout the ges-
tation, of which 12 fetuses were above 16 weeks of
gestation [17]. Sonographic findings of fetal radial
aplasia could be missed by prenatal two-dimensional
ultrasound [36], and three-dimensional ultrasound is
supposed to be a valuable adjunct to prenatal diag-
nosis of radial agenesis [37]. The poor sonographic
detection of limb anomalies may be associated with
maternal obesity, unfavorable fetal postures, earlier
sonographic scanning, and suboptimal visualization
of fetuses.
IUGR
IUGR is defined as less than 10th centile of predicted
fetal weight for gestational age. It may be diagnosed
at different trimesters. In a study of 47 trisomy 18
fetuses, IUGR was the most common sonographic
abnormality in trisomy 18 fetuses with an incidence
of 51% throughout the gestation, and the rate was
up to 89% for those older than 24 weeks of gesta-
tion [14]. In another study of 70 trisomy 18 fetuses,
only 11.4% were found with IUGR in the second
trimester [25]. In the first trimester screening, smaller
than expected crown-rump lengths (CRLs) in asso-
ciation with trisomy 18 have been reported, and
the restricted growth rate may be affected earlier
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in trisomy 18 fetuses than in either trisomy 13 or
triploidy [38,39].
CPCs
Fetal CPCs are fluid-filled cystic lesions within the
choroid plexus. It may appear transiently owing to
early fetal development and commonly resolves in
the mid-trimester. In the general population, the
prevalence of isolated CPC is around 1% [40,41].
In pregnancies complicated by isolated CPCs, the
prevalence of trisomy 18 is very low (0.13–0.9%)
[41,42]. The sizes, bilaterality and complexity of
the CPCs related to aneuploidy remain controversial.
In trisomy 18 fetuses, CPCs were seen in 25–50%
of cases, and most of them had other associated
abnormal features [14,15,17]. In clinical practice,
invasive genetic diagnosis is recommended when
prenatal ultrasound detects an additional major 
or minor anomaly in a fetus with CPCs in the 
mid-trimester [43].
Increased NT thickness and cystic hygroma
In the first trimester, NT refers to the sonographic
finding of a subcutaneous collection of fluid behind
the fetal neck. It is the sonographic measurement
of a maximal thickness of the echolucent zone
between the inner side of the fetal skin and the
outer side of the soft tissue covering the cervical
spine or the occipital bone during 11–13+6 weeks
of gestation, as proposed by the Fetal Medicine
Foundation (FMF) [44]. Increased fetal NT, equal
to or above the 95th centile of a reference range, is
significantly associated with chromosomal abnor-
malities [45]. The most sensitive sonographic find-
ing for trisomy 18 was increased NT (75%) under
16 weeks of gestation [17]. In a multicenter study
coordinated by the FMF, increased fetal NT was
identified in 74.8% (89/119) of trisomy 18 fetuses
[31]. First trimester screening, with a combination
of fetal NT and maternal serum proteins of free 
β-human chorionic gonadotropin (β-hCG) and
pregnancy-associated plasma protein-A (PAPP-A),
can identify approximately 90% of chromosomal
aneuploidies including trisomy 18, which repre-
sents a screen positive rate of 1% [31].
Nuchal cystic hygroma or nuchal edema is char-
acterized by abnormal fluid accumulation behind
the fetal neck after the second trimester or occasion-
ally in the first trimester. The definitive sonographic
findings include bilateral cystic structures or poste-
rior cystic structures with thick septations, which are
often associated with hydrops and adverse outcome.
Hyett et al [46] hypothesized that nuchal cystic
hygromas in trisomic fetuses may have resulted from
the mechanism of hemodynamic changes due to the
underlying cardiac anomalies. In a large database
in Europe, cystic hygroma was the most frequent
sonographic finding of trisomy 18 fetuses through-
out the gestation (26/120, 21.7%) [16]. Ville et al
[47] reported 56 cystic hygromas between 9 and
14 weeks of gestation and found chromosomal
abnormalities in 29%, of which trisomy 18 (38%)
was the most common karyotype.
Differential Diagnosis
Cytogenetic analysis is required for a definite diagno-
sis of fetal trisomy 18. The common structural abnor-
malities of fetal trisomy 18 remind us to consider
several other diseases, such as trisomy 18-like syn-
drome, Pena–Shokeir syndrome type I and AMC.
Trisomy 18-like syndrome (OMIM 601161)
Shashi et al [48] reported a newborn with complex
congenital heart defects and minor anomalies, sug-
gestive of trisomy 18. Her parents were consan-
guineous. Normal karyotype was demonstrated in
blood lymphocytes, skin fibroblasts, and kidney tis-
sue, except for only 17% of mosaic trisomy 18 in
the liver tissue. They concluded that mosaicism for
trisomy 18 in the liver might result from a laboratory
error, and a new autosomal recessive malformation
syndrome was proposed, considering the history of
parental consanguinity.
Pena–Shokeir syndrome type I (OMIM 208150)
Pena–Shokeir syndrome type I, also called fetal aki-
nesia deformation sequence, was first described by
Pena and Shokeir [49]. It is an autosomal recessive
Prenatal Sonography of Trisomy 18
71J Med Ultrasound 2007 • Vol 15 • No 2
and lethal disorder, characterized by multiple neu-
rogenic arthrogryposis, facial anomalies, and pul-
monary hypoplasia. Pulmonary hypoplasia often
results in early neonatal death. Primary motor neu-
ropathy is reported as a cause of the syndrome, and
the associated neuropathologic findings are cere-
bellar hypoplasia, thin cerebral and cerebellar cor-
tices, marked paucity of anterior horn cells in the
spinal cord, and diffuse muscle atrophy. Prenatal
diagnosis was first reported in 1985, with the find-
ings of polyhydramnios, abnormal skull shape,
nuchal edema, and a similarly abnormal fetus in a
previous pregnancy [50]. Pena–Shokeir syndrome
type I and trisomy 18 syndrome can have similar
prenatal sonographic findings, such as polyhydram-
nios, arthrogryposis and rocker-bottom feet [51].
The distinguishable sonographic features between
them are: scalp edema and lung hypoplasia in
fetuses with Pena–Shokeir syndrome type I, and
cardiac arrhythmias, prominent occiput, microg-
nathia and omphalocele in fetuses with trisomy 18.
AMC
AMC, with an incidence of 1/3,000, is a heteroge-
neous group of disorder [52]. It manifests as congen-
ital nonprogressive joint contractures in the upper
and lower limbs and/or the vertebral column, lung
hypoplasia, growth restriction, and facial anomalies
with normal intelligence [53,54]. Pathologic cate-
gories of AMC include myopathies, neuropathies,
connective tissue disorders, and exogenous effects
such as a limited intrauterine space. AMC may be
caused by either environmental factors or genetic
disorders. Several types involving single gene defects
are discussed here.
Autosomal dominant AMC syndrome (OMIM
108110) is characterized by various kinds of congen-
ital contractures, amyoplasia, and a round face with
a frontal midline capillary hemangioma and slightly
small jaw [55,56]. There are four types of autosomal
recessive AMC syndromes. Lethal congenital con-
tracture syndrome type 1 (OMIM 253310), mapping
to 9q34, is characterized by marked fetal hydrops,
multiple congenital contractures with akinesia,
micrognathia, the Pena–Shokeir phenotype with
lung hypoplasia, atrophy of the muscle, and paucity
of anterior horn motor neurons in the spinal cord
[57–59]. Lethal congenital contracture syndrome
type 2 (OMIM 607598), mapping to 12q13, is char-
acterized by multiple joint contractures, micro-
gnathia, markedly distended urinary bladder, and
craniofacial anomalies [60]. Compared with type 1,
type 2 lacks fetal hydrops, pterygia, and fractures.
Mid-trimester sonographic features, attributing to
fetal akinesia, limb contractures, hydramnios and dis-
tended urinary bladder, have been reported in type 2
[61]. AMC with neurogenic type (OMIM 208100),
mapping to 5q35, is a nonlethal type, and females
are less affected than males because of the possi-
bility of incomplete penetrance in females [62,63].
Arthrogryposis–renal dysfunction–cholestasis syn-
drome (OMIM 208085), caused by mutations in
VPS33B gene mapping to 15q26.1, manifests as a
neurogenic AMC with neonatal jaundice and renal
dysfunction, and those affected often die within the
first year of life [64,65]. X-linked distal AMC (OMIM
301830), mapping to Xp11.3–q11.2, manifests 
as congenital joint contractures, hypotonia, chest
deformities, facial dysmorphism, severe fetal mus-
cle weakness and loss of anterior horn cells in
males [66,67]. Several female carriers can have
mild features [68].
Sex Bias in Fetal Trisomy 18
Sex bias in many congenital anomalies has been
reported. In trisomy 18 live births, there is a signif-
icant excess of females. Statistically, the male to
female ratio for live births with trisomy 18 is around
0.6 and for fetuses, it is around 0.9 [27,69]. However,
there is little about the sex differences in trisomy
18 conceptuses. After conception, Huether et al
[70] reported a prenatal male to female ratio of 0.9
for trisomy 18 before and after 16 weeks of gesta-
tion and of 0.69 at birth. In detailed statistics of 93
trisomy 18 fetuses throughout the gestation in
Switzerland, the sex ratio was 1.02 between 10
and 15 weeks of gestation, 0.82 between 16 and
27 weeks and 0.52 between 28 and 43 weeks [69].
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Spontaneous pregnancy loss rate of trisomy 18 was
reported, ranging from 20% to 67% after amniocen-
tesis [8,9,71–73]. In another study conducted after
18 weeks of gestation, the authors found that the risk
for intrauterine demise in males was twice as high
as the risk for intrauterine demise in females [69].
In addition to a substantial prenatal loss of trisomy
18 males, the remaining male survivors after birth
seem to have a significantly shorter life span [9,28,
69,74–76]. In recent years, it is difficult to thoroughly
understand the spontaneous outcome for different
sex because of the increased elective abortions of tri-
somy 18 pregnancies after prenatal diagnosis [73].
To the best of our knowledge, the excessive loss
of trisomy 18 male fetuses was associated with more
severe congenital malformations, as observed by
Chen [24]. In his report, the more complex struc-
tural abnormalities in trisomy 18 males included
more complex CHD (57% in males vs. 33% in
females), more associated CNS anomalies (50% in
males vs. 33% in females), more associated
omphalocele (21% in males vs. 0% in females),
more associated CDH (14% in males vs. 7% in
females), and more associated arthrogryposis (64%
in males vs. 0% in females). Molecular analysis
revealed a male preponderance caused by maternal
meiosis II errors and a female preponderance caused
by maternal meiosis I errors. But no significant differ-
ence was noted in the associated structural abnor-
malities between maternal meiosis I errors, maternal
meiosis II errors and paternal errors [3].
Conclusion
With the advent of ultrasound equipment, the use
of prenatal ultrasound has greatly improved the
detection of aneuploid fetuses in obstetric practice.
Traditionally, second trimester maternal serum
screening test, combining α-fetoprotein, β-hCG and
unconjugated estriol, can detect only 60% of tri-
somy 18 fetuses [77]. Prenatal sonographic detec-
tion of fetuses with trisomy 18 was reported to 
be approximately 70–100%, and the contribution
of prenatal sonographic findings to the detection
of trisomy 18 increases significantly with the fetal
growth. Despite several diseases having phenotypic
overlaps with trisomy 18 syndrome, fetuses with
complex heart defects (such as septal and valvular
defects), limb defects (such as preaxial polydactyly,
clenched hand, arthrogryposis and limb deficiency),
CNS anomalies (such as cerebellar hypoplasia, micro-
cephaly, HPE, abnormal head shape, CPC, and facial
clefts), gastrointestinal anomalies (such as omphalo-
cele and CDH), and others (such as IUGR and cys-
tic hygromas) are strongly suggestive of trisomy 18,
and further fetal karyotyping is recommended. The
addition of sonographic soft markers, including
increased fetal NT and the absence of fetal nasal
bones, to the first trimester screening for trisomy 18
fetuses can significantly enhance the detection rate.
The increased understanding of the different
sonographic markers is helpful in detecting trisomy
18 fetuses, and prenatal ultrasound is an established
valuable tool to detect a variety of congenital
structural malformations throughout the gestation.
In addition, prenatal selection against male fetuses
was documented to be associated with more 
complex congenital anomalies. Early sonographic
identification of the major structural defects and
determination of fetal sex in trisomy 18 can provide
an appropriate genetic counseling and allow for a
more reasonable management for the pregnant
women.
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